Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPressure Tech Regulatory News (PRES)

  • There is currently no data for PRES

Analyst Briefing

7 Jun 2011 07:00

RNS Number : 9184H
Pressure Technologies PLC
07 June 2011
 



Analyst Briefing

 

As previously stated, Pressure Technologies plc will announce its interim results for the six month period ended 2 April 2011 on Tuesday, 14 June 2011. An analyst briefing will be held on that date at 10.30 am prompt at:

 

Fairfax IS PLC

46 Berkeley Square

MayfairLondon

W1J 5AT

 

Analysts interested in attending the briefing should contact Sally Annakin at Rawlings Financial PR Limited by e-mail: sally@rawlingsfinancial.co.uk or tel: 01653 618016.

 

 

For further information, please contact:

 

Pressure Technologies plc

John Hayward, Chief Executive

James Lister, Group Finance Director

 

Tel: 0114 242 7500

www.pressuretechnologies.co.uk

 

Fairfax IS PLC

Nominated Adviser and Broker

Ewan Leggat/Laura Littley

 

Tel: 0207 598 5368

Rawlings Financial PR Limited

Catriona Valentine

 

Tel: 01653 618 016

www.rawlingsfinancial.co.uk

 

 

Company description:

 

Pressure Technologies is an AIM listed, leading designer and manufacturer of speciality engineering solutions for high pressure systems serving large global markets.

 

The Group's largest subsidiary, Chesterfield Special Cylinders Limited ("CSC") designs, manufactures and offers retesting and refurbishment services for a range of speciality high pressure, seamless steel gas cylinders for global energy and defence markets. The business is conducted under the "Chesterfield" brand which is a long established name in the cylinders and specialised pressure vessel market.

 

Chesterfield BioGas Limited was formed in November 2008 following the signing of a co-operation agreement with Greenlane® Biogas Limited, the world leader in biogas upgrading. This gives Pressure Technologies exclusive rights to market and manufacture Greenlane® equipment in the UK and Eire. Chesterfield BioGas provides turnkey solutions for the cleaning, storage and dispensing of biomethane for injection into the gas grid or use as a vehicle fuel.

In 2010, the Engineered Products Division was formed following the purchase of Al-Met Limited ("Al-Met") and the Hydratron group of companies ("Hydratron").

Al-Met is a niche manufacturer of specialised, precision engineered valve wear parts used in the oil and gas industries, which was acquired by Pressure Technologies in February 2010. Its products are used in high-pressure choke and flow control valves, designed to regulate flow volumes in extremely demanding applications in the subsea and surface oil and gas industries. The business, which was established in 1985, has developed a leading edge capability in precision machining carbides, high grade stainless steels and super alloys.

Hydratron acquired on 15 October 2010, designs, manufactures and sells a range of air operated high pressure hydraulic pumps, gas boosters, power packs, hydraulic control panels and test rigs. Hydratron has sales and manufacturing companies in Altrincham, UK, and Houston, USA and a spread of third party distributors in key locations around the world. Formed in 1981, Hydratron has since established itself as a leading supplier of quality high pressure equipment to the oil and gas industries. The full range of Hydratron products may be viewed at www.hydratron.co.uk.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBGGDLXBGBGBL
Date   Source Headline
9th Feb 202111:00 amRNSPrice Monitoring Extension
9th Feb 20219:06 amRNSSecond Price Monitoring Extn
9th Feb 20219:00 amRNSPrice Monitoring Extension
9th Feb 20217:00 amRNSContract Win for Hydrogen Refuelling Stations
14th Jan 20217:00 amRNSPressure Technologies plc 2020 Preliminary Results
29th Dec 202011:06 amRNSSecond Price Monitoring Extn
29th Dec 202011:01 amRNSPrice Monitoring Extension
22nd Dec 20206:24 pmRNSHolding(s) in Company
21st Dec 20205:37 pmRNSHolding(s) in Company
21st Dec 20203:49 pmRNSHolding(s) in Company
21st Dec 20203:40 pmRNSHolding(s) in Company
17th Dec 20204:41 pmRNSHolding(s) in Company
17th Dec 202012:37 pmRNSResult of General Meeting
11th Dec 20204:40 pmRNSSecond Price Monitoring Extn
11th Dec 20204:35 pmRNSPrice Monitoring Extension
11th Dec 20202:06 pmRNSSecond Price Monitoring Extn
11th Dec 20202:00 pmRNSPrice Monitoring Extension
10th Dec 20204:42 pmRNSHolding(s) in Company
9th Dec 202011:21 amRNSHolding(s) in Company
7th Dec 20204:43 pmRNSHolding(s) in Company
7th Dec 20203:49 pmRNSHolding(s) in Company
4th Dec 20202:36 pmRNSHolding(s) in Company
3rd Dec 202010:55 amRNSHolding(s) in Company
1st Dec 20207:00 amRNSResult of Placing and PrimaryBid Offer
30th Nov 20204:36 pmRNSPrimaryBid Offer
30th Nov 20204:35 pmRNSProposed Placing and PrimaryBid Offer
3rd Nov 20207:00 amRNSFull Year Trading Update
21st Oct 20207:00 amRNSBoard Changes
30th Sep 20207:00 amRNSMajor Contracts and Trading Update
20th Aug 20207:00 amRNSBoard Changes
24th Jul 20204:26 pmRNSGrant of Share Options
3rd Jul 20207:35 amRNSDisposal of equity holding in Greenlane Renewables
23rd Jun 20207:01 amRNS2020 Interim Results
23rd Jun 20207:00 amRNSBoard changes
16th Apr 20202:08 pmRNSDirector Shareholding
14th Apr 20201:09 pmRNSDirector Shareholding
9th Apr 20207:00 amRNSUPDATE ON TRADING AND COVID-19 IMPACT
17th Mar 20207:00 amRNSDirector Shareholding
13th Mar 20207:00 amRNSDirector Shareholding
5th Mar 20207:00 amRNSResult of AGM
28th Feb 20203:00 pmRNSDirector Shareholding
25th Feb 202011:15 amRNSFurther re: Proposed Offering by Greenlane
19th Feb 20207:00 amRNSDirector Shareholding
12th Feb 20207:00 amRNSFurther re: Proposed Offering by Greenlane
11th Feb 20204:40 pmRNSDirector Shareholding
11th Feb 20207:00 amRNSProposed offering by Greenlane Renewables Inc.
10th Feb 202011:19 amRNSPurchase of shares by a Director
30th Jan 20207:00 amRNSPublication of Annual Report and Notice of AGM
28th Jan 20207:00 amRNSBoard Change
23rd Jan 20207:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.